179 results on '"de Knegt, Robert J"'
Search Results
2. SAT-200-YI Statin use is associated with liver fibrosis regression in the general population: a longitudinal analysis of The Rotterdam Study
3. TOP-241-YI Longitudinal changes in liver stiffness measurements in a population-based screening cohort of 5, 517 participants
4. FRI-209 Differential prevalence and prognostic value of metabolic syndrome components among metabolic-dysfunction associated steatotic liver disease (MASLD) patients
5. SAT-035 The yield of routine post-operative doppler ultrasound to detect early post-liver transplantation vascular complications
6. FRI-200 Magnitude of steatotic liver disease before and after liver transplantation and the impact of immunosuppressive medication: a multidimensional study
7. SAT-197-YI Higher serum vitamin D levels is associated with lower MASLD prevalence and incidence: the Rotterdam study
8. SAT-462-YI The interplay between steototic liver disease and viral infections: systematic review, meta-analysis and data synthesis
9. Association of HBsAg levels with differential gene expression in NK, CD8 T, and memory B cells in treated patients with chronic HBV
10. Addition of PEG‐interferon to long‐term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg‐negative chronic hepatitis B
11. Progression of the FIB-4 index among patients with chronic HCV infection and early liver disease
12. Sustained response and HBsAg loss after nucleo(s)tide analogue discontinuation in chronic hepatitis B patients: the prospective SNAP study
13. The Yield of Routine Post-Operative Doppler Ultrasound to Detect Early Post-Liver Transplantation Vascular Complications
14. The new international nomenclature for steatotic liver disease: One step forward towards enhanced awareness for healthier life
15. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study
16. Nonalcoholic fatty liver disease, liver fibrosis, and structural brain imaging: The Cross‐Cohort Collaboration
17. Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study
18. An international multidisciplinary consensus statement on MAFLD and the risk of CVD
19. Reply: Is there survival bias? The etiologic analysis for the negative association between fatty liver and mortality in the elderly populations
20. Single-cell RNA sequencing of liver fine-needle aspirates captures immune diversity in the blood and liver in chronic hepatitis B patients
21. The Steatosis-associated fibrosis estimator (SAFE) score: validation in the general US population
22. Liver stiffness is associated with excess mortality in the general population driven by heart failure: The Rotterdam Study
23. Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?
24. Reply
25. Reply
26. Reply
27. Modifiable risk factors for fatty liver disease: Time to act
28. Plasma proteomic signature of fatty liver disease: The Rotterdam Study
29. Does NAFLD Prevalence Data Expire?
30. Patients treated with rituximab are poorly screened for hepatitis B infection: Data from a low-incidence country
31. End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients
32. Author Response: Association of Nonalcoholic Fatty Liver Disease and Fibrosis With Incident Dementia and Cognition: The Rotterdam Study
33. Hepatocellular Carcinoma Risk in Sub-Saharan African and Afro-Surinamese Individuals with Chronic Hepatitis B Living in Europe: An International Multicenter Retrospective Cohort Study
34. Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study
35. Reply to: Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
36. Sex-stratified associations between fatty liver disease and Parkinson's disease: The Rotterdam study
37. Spleen Stiffness Measurement Across the Spectrum of Liver Disease Patients in Real-World Practice
38. Plasma MicroRNA Signature of Alcohol Consumption: The Rotterdam Study
39. Reply to: “Liver stiffness, fatty liver disease and atrial fibrillation in the Rotterdam study: Some issues”
40. Liver stiffness not fatty liver disease is associated with atrial fibrillation: The Rotterdam study
41. Reply
42. Reply
43. Minimal Development of Liver Fibrosis in Adult Tolerant Liver Transplant Recipients Late After Immunosuppressive Drug Weaning and Transplantation
44. Epidemiology and management of hepatitis B and C in primary care in the Netherlands: data from the Rijnmond Primary Care database
45. Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
46. Fatty liver disease is not associated with increased mortality in the elderly: A prospective cohort study
47. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination
48. Evaluation of nonalcoholic fatty liver disease (NAFLD) in severe obesity using noninvasive tests and imaging techniques
49. Tamoxifen use and potential effects on liver parenchyma: A long‐term prospective transient elastographic evaluation
50. Associations of Sex Steroids and Sex Hormone-Binding Globulin with Non-Alcoholic Fatty Liver Disease: A Population-Based Study and Meta-Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.